Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Blood Clot

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Blood Clot in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ono, A1
Westein, E1
Hsiao, S1
Nesbitt, WS1
Hamilton, JR1
Schoenwaelder, SM1
Jackson, SP1
Hidaka, H1
Ichikawa, A1

Reviews

1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Blood Clot

ArticleYear
[Signal-transduction therapy].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 108, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium

1996

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Blood Clot

ArticleYear
Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth.
    Blood, 2008, Jul-01, Volume: 112, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blood Platelets; Clot Retraction; Fibrin; He

2008